In a regulatory filing, Treace Medical (TMCI) disclosed that its CEO John Treace bought 60K shares of common stock on March 4th in a total transaction size of $524K. Shares of Treace Medical are up 4% afterhours at $9.20.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue